As the peak of the 2020-2021 flu season approaches in the US, InCrowd wanted to understand the perceptions and expectations of HCPs on patient and facility response to both the flu vaccine and the COVID-19 vaccine, and how both of these coinciding viruses will influence one another through the rest of 2020 and 2021.
* Please note, views in this survey reflect opinions only as reported by responding physicians.
Methodology:
- Method:
- 6-Minute MicroSurvey via InCrowd
- Crowds:
- Healthcare Practitioners (HCPs) that administer the flu vaccine
- Sample Size:
- n = 334
- Office-based, hospital, and retail
- n = 334
- Fielding Period:
- December 2nd – 8th
InCrowd’s other COVID-19 Tracking Reports:
-
- InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 2
- Telemedicine & Remote-Patient Monitoring Report
- Physician Tracking Report – Wave 6
- Non-Frontline Specialist Tracking Report – Wave 2
- Patient Tracking Report – Wave 3
- Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic
